Related Experiment Videos
Summary
Vitamin B6 (pyridoxine) supplementation helps prevent nerve damage (peripheral neuropathy) in patients taking isoniazid (INH) medication. Routine pyridoxine is recommended for high-risk groups to avoid this common side effect.
Area of Science:
- Biochemistry
- Pharmacology
- Neurology
Background:
- Isoniazid (INH) therapy is a cornerstone treatment for tuberculosis.
- INH can induce peripheral neuropathy, a debilitating side effect.
- Pyridoxine (Vitamin B6) is essential for various metabolic functions, including neurotransmitter synthesis.
Purpose of the Study:
- To review the frequency of INH-induced neuropathy.
- To identify patient populations at high risk for developing INH-induced neuropathy.
- To recommend pyridoxine supplementation to prevent INH-induced neuropathy.
Main Methods:
- Literature review of studies reporting INH-induced neuropathy.
- Analysis of risk factors associated with neuropathy development.
- Evaluation of pyridoxine's role in preventing neuropathy.
Main Results:
- INH therapy is associated with peripheral neuropathy in a significant number of patients.
- Certain patient groups exhibit a higher risk of developing INH-induced neuropathy.
- Pyridoxine plays a crucial role in mitigating INH's inhibitory effects on essential metabolic pathways.
Conclusions:
- Pyridoxine supplementation is a viable strategy to prevent peripheral neuropathy during INH therapy.
- Routine pyridoxine administration is recommended for individuals at high risk of INH-induced neuropathy.
- Understanding the biochemical interaction between INH and pyridoxine is key to managing treatment side effects.